DermTech to Present at the William Blair Growth Stock Conference

DermTech to Present at the William Blair Growth Stock Conference

LA JOLLA, Calif.–(BUSINESS WIRE)–
DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that management is scheduled to present at the William Blair Growth Stock Conference on Wednesday, June 8, 2022 at 2:00 p.m. CT. A live webcast of the presentation will be available on the investor relations section of DermTech’s website at https://investors.dermtech.com/news-events/events. A replay of the webcast will be archived for 90 days following the conference.

About DermTech

DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech’s mission is to improve the lives of millions by providing non-invasive precision dermatology solutions that enable individualized care. DermTech provides genomic analysis of skin samples collected non-invasively using our Smart StickersTM. DermTech markets and develops products that facilitate the early detection of skin cancers and is developing products that assess inflammatory diseases and customize drug treatments. For additional information, please visit DermTech.

Steve Kunszabo

DermTech

(858) 291-1647

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Biotechnology General Health Health Pharmaceutical Oncology

MEDIA:

Public Storage Virtual Presentation at Nareit REITweek 2022 to be Webcast

Public Storage Virtual Presentation at Nareit REITweek 2022 to be Webcast

GLENDALE, Calif.–(BUSINESS WIRE)–
Public Storage (NYSE:PSA) announced today that the Company will make a virtual presentation at REITweek 2022 on Wednesday, June 8, 2022, from 9:30 a.m. to 10:00 a.m. (ET). The presentation will be webcast and available to registered REITweek participants. Registration is complimentary and accessible through Nareit’s website.

Company Information

Public Storage, a member of the S&P 500 and FT Global 500, is a REIT that primarily acquires, develops, owns, and operates self-storage facilities. At March 31, 2022, we had: (i) interests in 2,797 self-storage facilities located in 39 states with approximately 199 million net rentable square feet in the United States, (ii) an approximate 35% common equity interest in Shurgard Self-Storage SA (Euronext Brussels:SHUR), which owned 254 self-storage facilities located in seven Western European nations with approximately 14 million net rentable square feet operated under the Shurgard® brand, and (iii) an approximate 41% common equity interest in PS Business Parks, Inc. (NYSE:PSB), which owned and operated approximately 27 million rentable square feet of commercial space at March 31, 2022. Our headquarters are located in Glendale, California.

Additional information about Public Storage is available on the Company’s website at PublicStorage.com.

Ryan Burke

(818) 244-8080, Ext. 1141

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Oracle Purchase of Cerner Approved

PR Newswire


AUSTIN, Texas
, June 1, 2022 /PRNewswire/ — Today, Oracle Corporation (NYSE: ORCL) announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance. Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities.

Oracle expects to complete the tender offer promptly following the expiration of that offer at midnight Eastern time on June 6, 2022. Completion of the tender offer remains subject to the conditions described in the tender offer statement on Schedule TO filed by Oracle with the U.S. Securities and Exchange Commission on January 19, 2022, as amended.

Oracle Chairman and Chief Technology Officer Larry Ellison will discuss the Cerner acquisition and Oracle’s new suite of cloud-based health management applications at an online event on June 9, 2022, at 3:00 p.m. CT. Register for the event

“Working together, Cerner and Oracle have the capability to transform healthcare delivery by providing medical professionals with a new generation of healthcare information systems,” said Larry Ellison, Chairman and Chief Technology Officer, Oracle. “Better information enables better treatment decisions resulting in better patient outcomes. Our new, easy-to-use systems are designed to lower the administrative workload burdening our medical professionals while improving patient privacy and lowering overall healthcare costs.”

“We expect this acquisition to be substantially accretive to Oracle’s earnings on a non-GAAP basis in fiscal year 2023,” said Safra Catz, Chief Executive Officer, Oracle. “Healthcare is the world’s largest and most important vertical market—$3.8 trillion last year in the United States alone. We expect Cerner to be a huge growth engine for years to come.”

“Cerner has been a leader in helping digitize medical care, and now it’s time to realize the real promise of that work with the care delivery tools that get information to the right caregivers at the right time,” said David Feinberg, Chief Executive Officer and President, Cerner. “Joining Oracle as a dedicated Industry Business Unit provides an unprecedented opportunity to accelerate our work modernizing electronic health records, improving the caregiver experience, and enabling more connected, high-quality and efficient patient care.”

Oracle’s Autonomous Database, APEX low-code development tools, and voice-enabled user interface enable us to rapidly modernize Cerner’s systems and move them to our next-generation Cloud,” said Mike Sicilia, Executive Vice President, Industries, Oracle. “This can be done very quickly because Cerner’s largest business and most important clinical system already runs on the Oracle Database. No change required there. What will change is the user interface. We will make Cerner’s systems much easier to learn and use by making hands-free voice technology the primary interface to Cerner’s clinical systems.”     

Highlights
  • All-cash tender offer for $95.00 per share, or approximately $28.3 billion, that is immediately accretive to Oracle’s earnings.
    • Substantially accretive to Oracle’s earnings on a non-GAAP basis in fiscal year 2023, and will contribute more to earnings thereafter.
    • Cerner will be a huge growth engine for Oracle for years to come as Oracle expands Cerner’s business into many more countries throughout the world.
    • The closing of the transaction is subject to satisfying certain closing conditions including Cerner stockholders tendering a majority of Cerner’s outstanding shares in the tender offer.
About Oracle

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at oracle.com.

Trademarks

Oracle, Java, and MySQL are registered trademarks of Oracle Corporation.

Cautionary Statement Regarding Forward-Looking Statements

This document may contain certain forward-looking statements about Oracle and Cerner, including statements that involve risks and uncertainties concerning Oracle’s proposed acquisition of Cerner, anticipated customer benefits and general business outlook. When used in this document, the words “can”, “will”, “expect”, “opportunity”, “promises”, “goal” and similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements. Any such statement may be influenced by a variety of factors, many of which are beyond the control of Oracle or Cerner, that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this document due to a number of risks and uncertainties. Potential risks and uncertainties include, among others, the possibilities that the transaction will not close or that the closing may be delayed, that the anticipated synergies may not be achieved after closing, and that the combined operations may not be successfully integrated in a timely manner, if at all; general economic conditions in regions in which either company does business; the impact of the COVID-19 pandemic on how Oracle, Cerner and their respective customers are operating their businesses and the duration and extent to which the pandemic will impact Oracle’s or Cerner’s future results of operations; and the possibility that Oracle or Cerner may be adversely affected by other economic, business, and/or competitive factors. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Oracle or Cerner.

In addition, please refer to the documents that Oracle and Cerner, respectively, file with the U.S. Securities and Exchange Commission on Forms 10-K, 10-Q and 8-K. These filings identify and address other important factors that could cause Oracle’s and Cerner’s respective operational and other results to differ materially from those contained in the forward-looking statements set forth in this document. You are cautioned to not place undue reliance on forward-looking statements, which speak only as of the date of this document. Except as required by law, neither Oracle nor Cerner is under any duty to update any of the information in this document.

Additional Information about the Acquisition and Where to Find It

This communication does not constitute an offer to buy or solicitation of an offer to sell Cerner shares. This communication is for informational purposes only. The tender offer is not being made to, nor will tenders be accepted from, or on behalf of, holders of Cerner shares in any jurisdictions in which the making of the tender offer or the acceptance thereof would not comply with the laws of that jurisdiction.

The tender offer is being made pursuant to a tender offer statement on Schedule TO (including an Offer to Purchase, a related Letter of Transmittal and certain other tender offer documents) filed by Cedar Acquisition Corporation with the U.S. Securities and Exchange Commission on January 19, 2022, as amended or supplemented from time to time. In addition, on January 19, 2022, Cerner filed a Solicitation/Recommendation Statement on Schedule 14D-9 with the U.S. Securities and Exchange Commission related to the tender offer, which has been amended or supplemented from time to time. Holders of Cerner shares are urged to read these documents carefully (as each may be amended or supplemented from time to time) because they contain important information that holders of Cerner shares should consider before making any decision regarding tendering their Cerner shares. The Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, are available to all holders of Cerner shares at no expense to them. The tender offer materials and the Solicitation/Recommendation Statement are available for free at the U.S. Securities and Exchange Commission’s website at www.sec.gov.

Oracle and Cerner also file annual, quarterly and special reports and other information with the U.S. Securities and Exchange Commission, which are available at the U.S. Securities and Exchange Commission’s website at www.sec.gov.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-purchase-of-cerner-approved-301559551.html

SOURCE Oracle

iStar Announces Adjustment of Conversion Rate for Convertible Notes

PR Newswire


NEW YORK
, June 1, 2022 /PRNewswire/ — iStar Inc. (NYSE: STAR) announced today an adjustment to the conversion rate of its 3.125% Convertible Senior Notes due 2022 as a result of the common stock cash dividends to be paid on June 15, 2022.

The conversion price applicable to the outstanding Convertible Notes has been adjusted to $13.73 per share (72.8554 shares of iStar common stock per $1,000 principal amount of Notes) effective May 31, 2022 and subject to further adjustment as provided in the governing supplemental indenture. 

Notice of the conversion rate adjustment has been delivered to holders of the notes and U.S. Bank National Association, as trustee, in accordance with the terms of the supplemental indenture.

*                 *                 *

iStar Inc. (NYSE: STAR) is focused on reinventing the ground lease sector, unlocking value for real estate owners throughout the country by providing modern, more efficient ground leases on institutional quality properties. As the founder, investment manager and largest shareholder of Safehold Inc. (NYSE: SAFE), the creator of the modern ground lease industry, iStar is using its national investment platform and its historic strengths in finance and net lease to expand the use of modern ground leases within the $7 trillion institutional commercial real estate market. Recognized as a consistent innovator in the real estate markets, iStar specializes in identifying and scaling newly discovered opportunities and has completed more than $40 billion of transactions over the past two decades. Additional information on iStar is available on its website at www.istar.com.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/istar-announces-adjustment-of-conversion-rate-for-convertible-notes-301559526.html

SOURCE iStar Inc.

Steelcase to Webcast First Quarter Conference Call

GRAND RAPIDS, Mich., June 01, 2022 (GLOBE NEWSWIRE) — Steelcase Inc. (NYSE: SCS) will webcast a discussion of its first quarter fiscal year 2023 financial results on Thursday, June 23, 2022 at 8:30 a.m. ET. A link to the webcast will be available at http://ir.steelcase.com and a replay of the webcast will be available shortly after the call concludes. The news release detailing the financial results will be issued the previous day, June 22, 2022, after the market closes. 

Steelcase Inc. will hold its Annual Meeting of Shareholders on Wednesday, July 13, 2022, via live webcast at 11:00 a.m. ET. The webcast will be accessible at https://www.virtualshareholdermeeting.com/SCS2022. A replay will be available after the webcast concludes.

About Steelcase Inc. 
Organizations around the world trust Steelcase to help them create places that help people work better, be inspired and accomplish more. The company designs, manufactures and partners with other leading organizations to provide architecture, furniture and technology solutions – accessible through a network of channels, including over 800 Steelcase dealer locations. Steelcase is a global, industry-leading, and publicly traded company with fiscal 2021 revenue of $2.6 billion. For more information, visit www.steelcase.com.

Source: Steelcase
SC-GR

Investor Contact:   Media Contact:
Mike O’Meara   Katie Woodruff
Investor Relations     Corporate Communications
(616) 292-9274    (616) 915-8505



Pure Storage Announces First Quarter Fiscal 2023 Financial Results

PR Newswire

Q1 revenue growing 50% year-over-year

Record Q1 operating profit

Raised FY23 revenue outlook to $2.66 billion


MOUNTAIN VIEW, Calif.
, June 1, 2022 /PRNewswire/ — Today Pure Storage (NYSE: PSTG), the IT pioneer that delivers the world’s most advanced data storage technology and services, announced financial results for its fiscal first quarter ended May 8, 2022.

“Pure’s continuing success is the direct result of our consistent focus on innovation and operational excellence,” said Charles Giancarlo, Chairman and CEO, Pure Storage. “We are delivering industry leading products, building a data storage and management platform that is both powerful and easy to use, and providing exceptional customer experiences.” 

First Quarter Financial Highlights 

  • Revenue $620.4 million, up 50% year-over-year
  • Subscription services revenue $219.2 million, up 35% year-over-year
  • Subscription Annual Recurring Revenue (ARR) $899.8 million, up 29% year-over-year
  • Remaining Performance Obligations (RPO) $1.4 billion, up 26% year-over-year
  • GAAP gross margin 68.7%; non-GAAP gross margin 70.6%
  • GAAP operating loss $(4.6) million; non-GAAP operating income $85.4 million
  • GAAP operating margin (0.7)%; non-GAAP operating margin 13.8%
  • Operating cash flow $220.1 million; free cash flow $187.3 million
  • Total cash, cash equivalents, and investments $1.3 billion
  • Returned approximately $66 million in Q1 to stockholders through share repurchases

“We are very pleased with our exceptional performance this quarter, marking a strong start to the fiscal year,” said Kevan Krysler, CFO, Pure Storage. “Pure’s flash leadership makes us the best choice for customers who prioritize performance, reliability, and significantly reducing their energy consumption. Our solutions make a significant and immediate impact in reducing data center carbon emissions, delivering longer service lifetimes, and reducing e-waste.”

First Quarter Company Highlights

  • Commitment to Sustainability: Pure released its inaugural Environmental, Social, Governance (ESG) report, providing visibility into the company’s current metrics and setting commitments for making meaningful progress toward a better future for the global community. Key report highlights:
    • Pure enables businesses and organizations to drive out direct energy usage in their data storage systems by up to 80% compared to competitive all-flash products and even more compared to disk-based systems.
    • More than 97% of Pure arrays purchased six years ago are still in service, and benefiting from continual modernization through our Evergreen program.
    • As part of the company’s goal to reduce Scope 3 emissions, Pure is committing to further reducing product emissions by 66% per petabyte by 2030.
  • Market-Leading Portfolio Innovation:
    Pure Fusion and Portworx Data Services are now generally available, enabling customers to bring infrastructure and applications closer together with cloud-like automation and storage delivery for traditional and cloud-native applications. Additionally, Pure’s FlashBlade was recognized as a leader in the 2022 IDC MarketScape for Distributed Scale Out File Storage due to its ease of use, consistent performance at scale, metadata architecture, and customer experience.

  • Momentum Across Technology Partnerships: Pure announced new partnerships with Snowflake and Kyndryl, and an expanded partnership with Amazon Web Services (AWS) in Q1 to deliver expertise, mission-critical capabilities, and enablement programs to global enterprises.

  • Pure//Accelerate® techfest22 will take place in-person in Los Angeles and virtually on June 8. There is still time to register for this one-of-a-kind event which will include Pure’s biggest launch in five years, along with inspiring keynotes, customer stories, and sessions to drive innovation.

Second Quarter and FY23 Guidance


Q2 FY23


FY23

Revenue

Approx. $635 Million

Approx. $2.66 Billion

Non-GAAP Operating Income

$75 Million

$320 Million

Non-GAAP Operating Margin

Approx. 11.8%

Approx. 12%

These statements are forward-looking and actual results may differ materially. Refer to the Forward Looking Statements section below for information on the factors that could cause our actual results to differ materially from these statements. Pure has not reconciled its guidance for non-GAAP operating income and non-GAAP operating margin to their most directly comparable GAAP measures because certain items that impact these measures are not within Pure’s control and/or cannot be reasonably predicted. Accordingly, a reconciliation of these non-GAAP financial measures guidance to the corresponding GAAP measures is not available without unreasonable effort.

Conference Call Information

Pure will host a teleconference to discuss the first quarter fiscal 2023 results at 1:30 pm PT today, June 1, 2022. A live audio broadcast of the conference call will be available at the Pure Storage Investor Relations website, investor.purestorage.com. Pure will also post its earnings presentation to this website in advance of the call and post its prepared remarks to this website within 24 hours following completion of the call.

A replay will be available following the call on the Pure Storage Investor Relations website for two weeks at 1-866-813-9403 (or +44 204 525 0658 for international callers) with passcode 071754.

Upcoming Events

Pure is scheduled to participate at the following investor conferences:

Stifel 2022 Cross Sector Insight Conference 
Date: Tuesday, June 7, 2022
Pure Participants: Sanjot Khurana, VP, Investor Relations and Treasurer


William Blair 42nd Annual Growth Stock Conference 
Date: Thursday, June 9, 2022
Pure Participants: Rob Lee, Chief Technology Officer (CTO), and Kevan Krysler, Chief Financial Officer (CFO)

Bank of America Securities 2022 Global Technology Conference 
Date: Thursday, June 9, 2022
Pure Participants: Ajay Singh, Chief Product Officer (CPO), and Sanjot Khurana, VP, Investor Relations and Treasurer

About Pure Storage

Pure Storage gives technologists their time back. Pure delivers a modern data experience that empowers organizations to run their operations as a true, automated, storage as-a-service model seamlessly across multiple clouds. Pure helps customers put data to use while reducing the complexity and expense of managing the infrastructure behind it. And with a certified customer satisfaction score in the top one percent of B2B companies, Pure’s ever-expanding list of customers are among the happiest in the world.

Analyst Recognition

Leader in the 2021 Gartner Magic Quadrant for Primary Storage Arrays 
Leader in the 2021 Gartner Magic Quadrant for Distributed File Systems & Object Storage

Connect with Pure

Blog 
LinkedIn
Twitter 
Facebook 

Pure Storage, the Pure P Logo, Portworx, and the marks on the Pure Trademark List at www.purestorage.com/legal/productenduserinfo.html are trademarks of Pure Storage, Inc. Other names are trademarks of their respective owners. 

Forward Looking Statements

This press release contains forward-looking statements regarding our products, business and operations, including but not limited to our views relating to future period financial results, our sustainable growth strategy, our continued momentum and growth potential, particularly within our enterprise customer segment, our sustainability goals and benefits, the timing and magnitude of large customer orders, the potential for supply chain disruptions, the scope and duration of the COVID-19 pandemic and its impact on our business operations, liquidity and capital resources, employees, customers, inflation, financial results and the economy, demand for our products and subscription services, including Pure as-a-Service, our expectations regarding our product and technology differentiation, new customer acquisition, the continued success of the Portworx technology, and other statements regarding our products, business, operations and results. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements.

Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. The potential risks and uncertainties that could cause actual results to differ from the results predicted include, among others, those risks and uncertainties included under the caption “Risk Factors” and elsewhere in our filings and reports with the U.S. Securities and Exchange Commission, which are available on our Investor Relations website at investor.purestorage.com and on the SEC website at www.sec.gov. Additional information is also set forth in our Annual Report on Form 10-K for the year ended February 6, 2022. All information provided in this release and in the attachments is as of June 1, 2022, and Pure undertakes no duty to update this information unless required by law.

Key Business Metric

Subscription ARR is a key business metric that refers to total annualized contract value of all active subscription agreements, including Evergreen, on the last day of the quarter, plus on-demand revenue for the quarter multiplied by four.

Non-GAAP Financial Measures

To supplement our unaudited condensed consolidated financial statements, which are prepared and presented in accordance with GAAP, Pure uses the following non-GAAP financial measures: non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income (loss), non-GAAP operating margin, non-GAAP net income (loss), non-GAAP net income (loss) per share, and free cash flow.

We use these non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance and liquidity by excluding certain expenses and expenditures such as stock-based compensation expense, payments to former shareholders of acquired companies, payroll tax expense related to stock-based activities, amortization of debt discount and debt issuance costs related to long-term debt, amortization of intangible assets acquired from acquisitions, acquisition-related transaction and integration expenses, and costs associated with the exit of certain operations that may not be indicative of our ongoing core business operating results. Pure believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when analyzing historical performance and liquidity and planning, forecasting, and analyzing future periods. The presentation of these non-GAAP financial measures is not meant to be considered in isolation or as a substitute for our financial results prepared in accordance with GAAP, and our non-GAAP measures may be different from non-GAAP measures used by other companies.

For a reconciliation of these non-GAAP financial measures to GAAP measures, please see the tables captioned “Reconciliations of non-GAAP results of operations to the nearest comparable GAAP measures” and “Reconciliation from net cash provided by operating activities to free cash flow,” included at the end of this release.

 


PURE STORAGE, INC.

Condensed Consolidated Balance Sheets

(in thousands, unaudited)


At the End of


First Quarter of
Fiscal 2023


Fiscal 2022


Assets

Current assets:

  Cash and cash equivalents

$          455,237

$          466,199

  Marketable securities

836,725

947,073

  Accounts receivable, net of allowance of $1,030 and $945

345,933

542,144

  Inventory

41,301

38,942

  Deferred commissions, current

67,448

81,589

  Prepaid expenses and other current assets

127,967

116,232

    Total current assets

1,874,611

2,192,179

Property and equipment, net

207,289

195,282

Operating lease right-of-use-assets

112,926

111,763

Deferred commissions, non-current

163,550

164,718

Intangible assets, net

58,595

62,646

Goodwill

358,736

358,736

Restricted cash

10,544

10,544

Other assets, non-current

42,101

39,447

    Total assets

$        2,828,352

$       3,135,315


Liabilities and Stockholders’ Equity

Current liabilities:

  Accounts payable

$            58,668

$            70,704

  Accrued compensation and benefits

111,131

205,431

  Accrued expenses and other liabilities

84,292

78,511

  Operating lease liabilities, current

37,370

35,098

  Deferred revenue, current

577,348

562,576

    Total current liabilities

868,809

952,320

Long-term debt

572,556

786,779

Operating lease liabilities, non-current

91,639

93,479

Deferred revenue, non-current

535,125

517,296

Other liabilities, non-current

33,129

31,105

    Total liabilities

2,101,258

2,380,979

Stockholders’ equity:

  Common stock and additional paid-in capital

2,367,607

2,470,972

  Accumulated other comprehensive loss

(18,845)

(8,365)

  Accumulated deficit

(1,621,668)

(1,708,271)

    Total stockholders’ equity

727,094

754,336

    Total liabilities and stockholders’ equity

$        2,828,352

$       3,135,315

 


PURE STORAGE, INC.

Condensed Consolidated Statements of Operations

(in thousands, except per share data, unaudited)


First Quarter of Fiscal


2023


2022

Revenue:

  Product

$         401,161

$         249,888

  Subscription services

219,244

162,819

Total revenue

620,405

412,707

Cost of revenue:

  Product (1)

125,484

79,064

  Subscription services(1)

68,495

51,777

Total cost of revenue

193,979

130,841

Gross profit

426,426

281,866

Operating expenses:

  Research and development (1)

161,273

131,381

  Sales and marketing (1)

218,153

183,496

  General and administrative (1)

51,567

43,146

Total operating expenses

430,993

358,023

Loss from operations

(4,567)

(76,157)

Other income (expense), net

(6,181)

(4,727)

Loss before provision for income taxes

(10,748)

(80,884)

Income tax provision

787

3,322

Net loss

$          (11,535)

$          (84,206)

Net loss per share attributable to common stockholders, basic and diluted

$             (0.04)

$             (0.30)

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted

295,843

280,331

(1) Includes stock-based compensation expense as follows:

Cost of revenue — product

$             1,863

$             1,347

Cost of revenue — subscription services

5,356

4,406

Research and development

36,517

30,421

Sales and marketing

18,345

16,808

General and administrative

12,490

8,352

Total stock-based compensation expense

$           74,571

$           61,334

 


PURE STORAGE, INC.

Condensed Consolidated Statements of Cash Flows

(in thousands, unaudited)


First Quarter of Fiscal


2023


2022


Cash flows from operating activities

Net loss

$              (11,535)

$              (84,206)

Adjustments to reconcile net loss to net cash provided by operating activities:

  Depreciation and amortization

22,663

18,826

  Amortization of debt discount and debt issuance costs

801

7,403

  Stock-based compensation expense

74,571

61,334

  Other

146

2,621

Changes in operating assets and liabilities:

  Accounts receivable, net

196,129

133,380

  Inventory

(1,699)

(3,508)

  Deferred commissions

15,309

2,049

  Prepaid expenses and other assets

(11,742)

(30,407)

  Operating lease right-of-use assets

7,749

7,581

  Accounts payable

(7,419)

(24,354)

  Accrued compensation and other liabilities

(88,963)

(84,837)

  Operating lease liabilities

(8,480)

(6,897)

  Deferred revenue

32,602

22,463

Net cash provided by operating activities

220,132

21,448


Cash flows from investing activities

  Purchases of property and equipment(1)

(32,810)

(27,829)

  Purchases of marketable securities

(17,251)

(171,563)

  Sales of marketable securities

85,537

  Maturities of marketable securities

116,175

65,740

Net cash provided by (used in) investing activities

66,114

(48,115)


Cash flows from financing activities

  Net proceeds from exercise of stock options

11,405

8,016

  Proceeds from issuance of common stock under employee stock purchase plan

19,396

17,726

  Principal payments on borrowings and finance lease obligations

(251,395)

(344)

  Tax withholding on vesting of equity awards

(10,194)

(5,050)

  Repurchases of common stock

(66,420)

(30,020)

Net cash used in financing activities

(297,208)

(9,672)

Net decrease in cash, cash equivalents and restricted cash

(10,962)

(36,339)

Cash, cash equivalents and restricted cash, beginning of period

476,743

347,691

Cash, cash equivalents and restricted cash, end of period

$             465,781

$             311,352


(1) Includes capitalized internal-use software costs of $2.9 million and $1.3 million for the first quarter of fiscal 2023 and 2022.

Reconciliations of non-GAAP results of operations to the nearest comparable GAAP measures

The following table presents non-GAAP gross margins by revenue source before certain items (in thousands except percentages, unaudited):


First Quarter of Fiscal 2023


First Quarter of Fiscal 2022


GAAP


results


GAAP


gross


margin (a)


Adjustment


Non-


GAAP


results


Non-


GAAP


gross


margin (b)


GAAP


results


GAAP


gross


margin (a)


Adjustment


Non-


GAAP


results


Non-


GAAP


gross


margin (b)

$      1,863

(c)

$      1,347

(c)

188

(d)

78

(d)

3,199

(e)

3,067

(e)


Gross profit –product

$   275,677

68.7 %

$      5,250

$     280,927

70.0 %

$    170,824

68.4 %

$      4,492

$    175,316

70.2 %

$      5,356

(c)

$      4,406

(c)

582

(d)

243

(d)

135

(f)

24

(g)

24

(g)


Gross profit — subscription services

$   150,749

68.8 %

$      6,097

$    156,846

71.5 %

$    111,042

68.2 %

$      4,673

$    115,715

71.1 %

$      7,219

(c)

$      5,753

(c)

770

(d)

321

(d)

3,199

(e)

3,067

(e)

135

(f)

24

(g)

24

(g)


Total gross profit

$   426,426

68.7 %

$    11,347

$   437,773

70.6 %

$   281,866

68.3 %

$      9,165

$   291,031

70.5 %

(a) GAAP gross margin is defined as GAAP gross profit divided by revenue.

(b) Non-GAAP gross margin is defined as non-GAAP gross profit divided by revenue.

(c) To eliminate stock-based compensation expense.

(d) To eliminate payroll tax expense related to stock-based activities.

(e) To eliminate amortization expense of acquired intangible assets.

(f) To eliminate costs associated with the exit of certain operations.

(g) To eliminate payments to former shareholders of acquired company.

The following table presents certain non-GAAP consolidated results before certain items (in thousands, except per share amounts and percentages, unaudited):


First Quarter of Fiscal 2023


First Quarter of Fiscal 2022


GAAP


results


GAAP


operating


margin (a)


Adjustment


Non-


GAAP


results


Non-


GAAP


operating


margin (b)


GAAP


results


GAAP


operating


margin (a)


Adjustment


Non-


GAAP


results


Non-


GAAP


operating


margin (b)

$     74,571

(c)

$     61,334

(c)

1,800

(d)

5,675

(d)

6,996

(e)

3,791

(e)

2,868

(f)

3,730

(g)

3,600

(g)

2,043

(h)


Operating Income (loss)

$      (4,567)

-0.7 %

$     89,965

$     85,398

13.8 %

$     (76,157)

-18.5 %

$     76,443

$       286

0.1 %

$     74,571

(c)

$     61,334

(c)

1,800

(d)

5,675

(d)

6,996

(e)

3,791

(e)

2,868

(f)

3,730

(g)

3,600

(g)

2,043

(h)

801

(i)

7,403

(i)


Net income (loss)

$    (11,535)

$     90,766

$    79,231

$    (84,206)

$     83,846

$      (360)


Net income (loss) per share — diluted

$        (0.04)

$         0.25

$       (0.30)

$     (0.00)


Weighted-average shares used in per share calculation —  diluted

295,843

20,037

(j)

315,880

280,331

280,331

(a) GAAP operating margin is defined as GAAP operating loss divided by revenue.

(b) Non-GAAP operating margin is defined as non-GAAP operating loss divided by revenue.

(c) To eliminate stock-based compensation expense.

(d) To eliminate payments to former shareholders of acquired companies.

(e) To eliminate payroll tax expense related to stock-based activities.

(f) To eliminate costs primarily associated with the exit of certain operations.

(g) To eliminate amortization expense of acquired intangible assets.

(h) To eliminate acquisition-related transaction and integration expenses.

(i) To eliminate amortization expense of debt discount and debt issuance costs related to our long-term debt.

(j) To include effect of dilutive securities (employee stock options, restricted stock, and shares from employee stock purchase plan). 

Reconciliation from net cash provided by operating activities to free cash flow (in thousands except percentages, unaudited):


First Quarter of Fiscal


2023


2022

Net cash provided by operating activities

$             220,132

$               21,448

Less: purchases of property and equipment(1)

(32,810)

(27,829)

Free cash flow (non-GAAP)

$             187,322

$                (6,381)


(1) Includes capitalized internal-use software costs of $2.9 million and $1.3 million for the first quarter of fiscal 2023 and 2022.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/pure-storage-announces-first-quarter-fiscal-2023-financial-results-301559527.html

SOURCE Pure Storage

Thornburg Income Builder Opportunities Trust Announces Distribution

PR Newswire


SANTA FE, N.M.
, June 1, 2022 /PRNewswire/ — Thornburg Income Builder Opportunities Trust (the “Trust”) (NASDAQ: TBLD) today announced a monthly distribution of $0.10417 per share on the Trust’s common shares, payable on June 21, 2022 to common shareholders of record as of June 13, 2022.

The Trust’s monthly distributions are shown below:



Amount



Payable Date



Ex-Dividend Date



Record Date



Change from Previous
Declaration



$0.10417

June 21, 2022

June 10, 2022

June 13, 2022

No Change

Distribution rates are not performance and are calculated by summing the Trust’s monthly distribution per share over four quarters and dividing by the net asset value or market price per share, as applicable, as of the distribution announcement date. Distributions on common shares are generally paid from net investment income (regular interest and dividends) and may also include capital gains and/or a return of capital. The Trust’s distribution payable on June 21, 2022, does not include a return of capital but includes short-term capital gains in the amount of $0.08329. The specific tax characteristics of the distributions will be reported to the Trust’s common shareholders on Form 1099 after the end of the 2022 calendar year. The final determination for all distributions paid in 2022 will be made in early 2023 and reported to you on Form 1099-DIV. You should not use this notice as a substitute for your 1099-DIV.

Shareholders should not assume that the source of a distribution from the Trust is net income or profit. A distribution comprised in whole or in part by a return of capital does not necessarily reflect the Trust’s investment performance and should not be confused with “yield” or “income.” Future distributions may consist of a return of capital. For further information regarding the Trust’s distributions, please visit www.thornburg.com/tbld-distributions.

The Trust’s investment objective is to provide current income and additional total return. The Trust seeks to achieve its objective by investing, directly or indirectly, at least 80% of its managed assets in a broad range of income-producing securities. The Trust invests in both equity and debt securities of companies located in the United States and around the globe. The Trust may invest in non-U.S. domiciled companies, including up to 20% of its managed assets at the time of investment in equity and debt securities of emerging market companies.

As a registered investment company, the Trust is subject to a 4% excise tax that is imposed if the Trust does not distribute to common shareholders by the end of any calendar year at least the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on October 31 of the calendar year (unless an election is made to use the Trust’s fiscal year). In certain circumstances, the Trust may elect to retain income or capital gain to the extent that the Board of Trustees, in consultation with Trust management, determines it to be in the interest of shareholders to do so.

The common share distributions paid by the Trust for any particular period may be more than the amount of net investment income from that period. As a result, all or a portion of a distribution may be a return of capital, which is in effect a partial return of the amount a common shareholder invested in the Trust, up to the amount of the common shareholder’s tax basis in their common shares, which would reduce such tax basis. Although a return of capital may not be taxable, it will generally increase the common shareholder’s potential gain, or reduce the common shareholder’s potential loss, on any subsequent sale or other disposition of common shares.


About Thornburg

Thornburg is a global investment firm delivering on strategy for institutions, financial professionals and investors worldwide. The privately held firm, founded in 1982, is an active, high-conviction manager of fixed income, equities, multi-asset solutions and sustainable investments. With $44 billion1 in client assets as of April 30, 2022, the firm offers mutual funds, closed-end funds, institutional accounts, separate accounts for high-net-worth investors and UCITS funds for non-U.S. investors.

As an independent firm, Thornburg can take on a wide range of opportunities, explore ideas thoroughly and work across strategies to deliver consistent risk-adjusted outperformance over the long term. The firm attracts free-thinking professionals who are eager to pursue investment outcomes beyond the confines of popular wisdom. From nimble operational capabilities to principles and actions fitting of a global citizen, Thornburg’s world-class investment platform and team are aligned on strategy to serve investors.

Thornburg’s U.S. headquarters is in Santa Fe, New Mexico with offices in London, Hong Kong and Shanghai. For more information, visit www.thornburg.com or call 877 215 1330.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any offer, solicitation or sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction. A registration statement relating to these securities has been filed with and declared effective by the U.S. Securities and Exchange Commission.

Before investing, carefully consider the Trust’s investment goals, risks, charges, and expenses. For a prospectus or summary prospectus containing this and other information, contact your financial advisor, visit www.thornburg.com/tbld, or call 877 215 1330. Read them carefully before investing.

Certain statements in this press release constitute forward-looking statements, which involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Trust, or industry results, to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. As a result, no assurance can be given as to future results, levels of activity, performance or achievements, and neither the Trust nor any other person assumes responsibility for the accuracy and completeness of such statements in the future.

Risk is inherent in all investing. There can be no assurance that the Trust will achieve its investment objective, and you could lose some or all of your investment.

NOT FDIC INSURED      NO BANK GUARANTEE      MAY LOSE VALUE

Thornburg Securities Corporation, Distributor


Media Inquiries
 
Michael Corrao
Director of Global Communications
Thornburg Investment Management
Tel: +1 505 467 5345
Email: [email protected]

1 Includes $42 billion in assets under management and $2 billion in assets under advisement as of April 30, 2022.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thornburg-income-builder-opportunities-trust-announces-distribution-301559482.html

SOURCE Thornburg Investment Management

Gabelli Utilities Fund Reaffirms $0.88 Distribution Policy and Announces New C1 Class

Gabelli Utilities Fund

Reaffirms $0.88 Distribution Policy

and Announces New C1 Class

RYE, N.Y.–(BUSINESS WIRE)–
The Board of Trustees (the “Board”) of The Gabelli Utilities Fund (the “Fund”) reaffirmed the Fund’s annual distribution rate of $0.88 per share for Class I, Class A, Class AAA, and Class C shareholders. This represents $0.07 per share for the first two months of each quarter and $0.08 per share in the final month of each quarter.

The Board also announced Class C shares (ticker: GAUCX) were renamed Class C1. Existing Class C1 shares will remain available for existing holders at their election, and will be available for additional investment through August 31, 2022.

A new Class C share (ticker: GUXPX) is expected to become available for sale on or about September 1, 2022. The new Class C shares, which will have similar attributes to the Class C1 shares, will have an annual distribution rate of $0.88 per share. The new Class C shares will have a cash distribution of approximately 11% of NAV at inception, a similar rate to Class I, Class A, and Class AAA shares.

The Gabelli Utilities Fund is managed by Gabelli Funds, LLC and distributed by G.distributors, LLC, subsidiaries of GAMCO Investors, Inc. (NYSE: GBL).

You should not draw any conclusions about the Fund’s investment performance from the amount of the past distributions. The Fund’s distribution policy is subject to modification or termination by the Board at any time. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund. The Fund’s distributions may be comprised of net investment income, capital gains, and paid in capital.

Investors should carefully consider the investment objectives, risks, sales charges, and expenses of the Fund before investing. The prospectus and summary prospectus contain information about these and other matters and should be read carefully before investing. To obtain a prospectus or summary prospectus, please visit our website at www.gabelli.com or call 800-GABELLI (800-422-3554).

For Information:

Please call 800-GABELLI

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Other Professional Services Professional Services Finance

MEDIA:

Atreca Announces Corporate Reorganization to Extend Cash Runway

Company continuing to advance ATRC-101, ATRC-301 and other oncology pipeline assets

Extends cash runway through 2023 and reduces workforce by more than 25%

On track to report data from ATRC-101 and ATRC-301 programs in 2H2022

SAN CARLOS, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced a corporate reorganization to extend its cash runway through 2023, including a workforce reduction of more than 25%. Atreca will remain focused on the development of ATRC-101, ATRC-301, and its other preclinical oncology programs, and will continue efforts to generate new lead antibodies against tumor specific targets utilizing its proprietary discovery platform.

“While we are taking steps to significantly streamline our operations, we remain committed to the development of ATRC-101 and ATRC-301, the advancement of earlier-stage assets, and the discovery of additional novel tumor-targeting lead antibodies using our platform,” said John Orwin, Chief Executive Officer of Atreca. “We look forward to sharing additional monotherapy and combination data from the ongoing Phase 1b clinical trial of ATRC-101, as well as key preclinical toxicology data from the ATRC-301 program, later this year. While it is difficult to part with so many talented and valued members of our team, we view this as a necessary step to ensure we have the capital required to execute on our mission to deliver novel therapeutics to patients in need. I’d like to thank those leaving Atreca for their important contributions to the Company.”


Corporate Updates and Revised Guidance

  • Atreca has extended its guidance on cash runway through the end of 2023 as a result of revisions to its operating plan and a workforce reduction of more than 25%, including both current employees and open positions.
  • Atreca still plans to present updated monotherapy and pembrolizumab combination data from the Phase 1b clinical trial of ATRC-101 in the second half of 2022.
  • Initial non-human primate toxicology data in the ATRC-301 development program remains expected in the second half of 2022.
  • Based on the efficiency of its discovery platform, Atreca continues to target one additional investigational new drug, or IND, filing per year beginning with ATRC-301 in 2023.
  • The chemotherapy combination arm of the ATRC-101 Phase 1b clinical trial is no longer expected to initiate enrollment in 2022.

“In 2022 so far, we’ve not only named our next clinical candidate, ATRC-301, an antibody drug conjugate targeting EphA2, but we’ve disclosed multiple lead-stage oncology programs, all generated via our discovery platform,” said Tito A. Serafini, Ph.D., Chief Strategy Officer and Founder of Atreca. “Given the productivity of our platform, and the validation provided by ATRC-101 clinical activity reported earlier this year, we remain committed to leveraging the platform for the continued growth of our pipeline, while also supporting the development of existing programs. We sincerely thank our team, including those who are leaving Atreca, for working so creatively and diligently to build a highly efficient and scalable platform in service of delivering potential medicines to patients with unmet needs.”

About Atreca, Inc.

Atreca is a biopharmaceutical company developing novel antibody-based immunotherapeutics generated by its differentiated discovery platform. Atreca’s platform allows access to an unexplored landscape in oncology through the identification of unique antibody-target pairs generated by the human immune system during an active immune response against tumors. These antibodies provide the basis for first-in-class therapeutic candidates, such as our lead product candidate ATRC-101, a monoclonal antibody targeting a novel ribonucleoprotein complex, as well as ATRC-301, an antibody drug conjugate targeting a novel epitope on EphA2. A Phase 1b study evaluating ATRC-101 in multiple solid tumor cancers is currently enrolling patients, and ATRC-301 is in IND-enabling studies. For more information on Atreca, please visit www.atreca.com

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “will,” “intend,” “continue,” “look forward,” “guidance,” “ongoing,” “plan,” “expect,” “next,” “potential” and similar words, are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our strategy and future plans; the extension of our cash runway through 2023; [estimated severance and employment termination-related expenses]; the development of ATRC-101, ATRC-301, and our preclinical and clinical plans and the timing thereof, specifically, plans to present data from the Phase 1b clinical trial of ARTC-101 and initial non-human toxicology data from the ATRC-301 development program in the second half of 2022; Atreca’s ability to submit an IND application for ATRC-301 in 2023; and Atreca’s ability to continue to develop new clinical candidates for IND applications and ability to submit one such application per year. Our actual results may differ materially from those indicated in these forward-looking statements due to risks and uncertainties related to the initiation, timing, progress and results of our research and development programs, preclinical studies, clinical trials, regulatory submissions, and other matters that are described in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) and available on the SEC’s website at www.sec.gov, including the risk factors set forth therein. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release, and we undertake no obligation to update any forward-looking statement in this press release, except as required by law.

Contacts

Atreca, Inc.
Herb Cross
Chief Financial Officer
[email protected]

Investors:
Alex Gray, 650-779-9251
[email protected]

Media:
Julia Fuller, 858-692-2001
[email protected]

Source: Atreca, Inc.



Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CARLSBAD, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on June 1, 2022 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in May 2022. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

The employees received, in the aggregate, 10,000 restricted stock units (“RSUs”). One-fourth of the RSUs granted to each employee will vest yearly on each anniversary of the grant date, such that the RSUs granted to each employee will be fully vested on the fourth anniversary of the grant date, in each case, subject to each such employee’s continued employment with Acutus on such vesting date.

About Acutus Medical, Inc.

Acutus is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

Caution Regarding Forward-Looking Statements

This press release includes statements that may constitute “forward-looking” statements, usually containing the words “will,” “believe,” “estimate,” “project,” “expect” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company’s ability to continue to manage expenses and cash burn rate at sustainable levels, continued acceptance of its products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase the Company’s systems and the timing of such purchases, competitive factors, changes resulting from healthcare policy in the United States and globally, including changes in government reimbursement of procedures, dependence upon third-party vendors and distributors, timing of regulatory approvals, the impact of the coronavirus (COVID-19) pandemic and Acutus’ response to it, and other risks discussed in the Company’s periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, Acutus undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Investor Contact: Media Contact:
Caroline Corner Holly Windler
Westwicke ICR M: 619-929-1275
D: 415-202-5678
[email protected]

[email protected]